Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial

Lane, HY; Tu, CH; Lin, WC; Lin, CH

Lin, CH (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Psychiat, Coll Med, 123 Dapi Rd, Kaohsiung 833, Taiwan.

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021; 24 (5): 392

Abstract

Background: Current anti-dementia drugs cannot benefit mild cognitive impairment (MCI). Sodium benzoate (a D-amino acid oxidase [DAO] inhibitor) has b......

Full Text Link